Clinical trial
Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed…
NCT00004916 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004916 |
|---|---|
| Title | Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma |
| Official title | Phase I/II Study of Mesna, Ifosfamide, Teniposide and Weekly Taxol (MITTen) in Relapsed Lymphoma |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | ifosfamide, paclitaxel, teniposide, peripheral blood stem cell transplantation |
| Start date | Feb 1, 1999 |
| Primary completion | Oct 1, 2002 |
| Completion | Oct 1, 2002 |
| First posted | May 14, 2003 |
| Last update posted | Jun 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: